TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Perceived effectiveness and acceptability of e-learning program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Confidence and preparedness to implement new skills
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Ability to deliver remote care following training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Progression (TTPd)
Endpoint domain: Mortality/survival
Primary endpoint: Mean change in Fasting Plasma Glucose (FPG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Specificity for detection of early SCC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Gastrointestinal recovery time (GI-2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of prolonged postoperative ileus (POI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HIV-1 acquisition risk reduction
Endpoint domain: Mortality/survival
Primary endpoint: Reproducibility of TKV measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User confidence with TKV measurement instructions
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Breastfeeding satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: First lactation period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum Comfort Questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: average loss of bone in the bucco-palatal width
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average decrease in soft tissue topography height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Following treatment advice
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: FAAM Activities of Daily Living scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF‐36 Physical Component Summary Scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: suture quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: dominant hand dexterity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mini‐Profile of Music Perception Skills test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Successful guidance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Total time required for procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postoperative emergence agitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to discharge from post anesthesia care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sperm retrieval rate (SRR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Global distress index
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Hematologic Improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: long-term disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nicotine levels maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer of dependence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of EUGR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cardiometabolic allostatic load
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Spike IgG geometric mean ELISA titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neutralizing antibodies levels (FRNT50 geometric mean values)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events (low-grade injection site tenderness and pain)
Endpoint domain: Adverse events/effects
Primary endpoint: Effectiveness in discouraging vaping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of appropriate proton pump inhibitor use during hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of potentially inappropriate proton pump inhibitor use at discharge
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: BCVA scores improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CMT measurements decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: photographic appearance of facial scars
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stroke knowledge scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of anhedonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total MPQ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PPT increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS-ADL score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KOOS-Sports score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total TSI scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Expression levels of CD56(dim) NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression levels of CD56(bright) NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: IFN-gamma secretion level of Tim3(+) NK cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of Clavien‐Dindo grade III‐IV intra‐abdominal abscess
Endpoint domain: Adverse events/effects
Primary endpoint: Full Scale Intelligence Quotient (FSIQ) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Total success rate of NGT insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time required for NGT insertion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of DTG-based ART in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completeness rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: repeat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of any recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Relative changes in BMFC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intravenous morphine equivalent dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OFF hours/day reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ON time without troublesome dyskinesia (ON-WoTD) increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TLF (Target Lesion Failure)
Endpoint domain: Mortality/survival
Primary endpoint: NACE (Net Adverse Clinical Events)
Endpoint domain: Mortality/survival
Primary endpoint: Modified Rankin Scale score of 0–2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate or severe mental fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Residual or de novo aneurysm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Maximum late genitourinary toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum late gastrointestinal toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Biochemical failure
Endpoint domain: Adverse events/effects
Primary endpoint: Hypertension status at home
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patient satisfaction with the study
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: percent days abstinent
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Antibiotic Use (AU) reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cholesterol and low-density lipoprotein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Session count ratio unsupervised/supervised
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Propofol plasma concentration at BIS=50
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety symptomatology
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Global efficiency of brain networks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Functional connectivity of prefrontal sub-network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Likelihood of relapse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cumulative incidence of vomiting
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Clinically important pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postintervention UIC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Cognitive composite score on the Bayley-III
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: serum butyrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Body movements during surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Inconclusive test results
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite outcomes for inconclusive tests
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Twenty-four-month costs for inconclusive tests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Proportion of vitamin K subclinical sufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median PIVKA‐II levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: process-of-care endpoints
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reductions in tic severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional connectivity between thalamus and brain areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: SSD in A-P cartilage contact center
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Degree of fibrosis at post-treatment MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAGNIFI-CD index at post-treatment MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: JTC-bias rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Copper ion penetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation and retention in drug treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Urinary excretion of Se and Zn
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: failures directly related to fiber posts cementation strategy
Endpoint domain: Mortality/survival
Primary endpoint: Knowledge of obstetric danger signs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: GAIS response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: within-day learning in finger independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: consolidation of learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of LAGE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: corrected vision improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: macular thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: kynurenine/tryptophan ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: hs‐troponin T
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in mean horizontal ridge dimension (BPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of secondary PTH within 4 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PTH degree
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative change in defect height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reduction in defect size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MBL increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean serum vitamin B12 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean serum folate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean blood hemoglobin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: practice frequency
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: UTI recurrence
Endpoint domain: Mortality/survival
Primary endpoint: fUTI recurrence
Endpoint domain: Mortality/survival
Primary endpoint: 90-day readmission
Endpoint domain: Mortality/survival
Primary endpoint: Change in self-efficacy scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: sleep self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: perceived time spent during rounds
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: actual time spent during rounds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: top-box experience responses
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fasting glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Homeostasis model assessment insulin resistance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction of β2M levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction of PTH levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in pruritus score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in lesion color, thickness, and size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Downtime
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Utilization of paraphrasing and client-directed eye gaze
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single Assessment Numeric Evaluation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cystoid macular edema occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: Moderate-to-severe exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morning trough FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Optimization of physical activity (PA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Appreciation of digital support in OA care
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Fold-rise of anti-spike IgG geometric mean titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in nanohardness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in modulus of elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Topographical changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CXA improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: active function improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binge-eating remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5% weight loss rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toothbrushing behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total cumulative health care costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: allergen-specific IgE in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Th2 cells in blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Th2 cells in BAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Cumulative grade 3–5 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Discontinuation of PPIUD use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Partial or complete expulsions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of children with overweight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment failure during hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: PaCO2 levels after 24 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mild pain 6 hours postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIA-scores during mobilisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for type of HIV self-testing (HIVST)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Reduction in talonavicular coverage angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in first talometatarsal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Reduction in second talometatarsal angle
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Interproximal marginal bone level regeneration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Width of the alveolar crest change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular UIVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: binocular UNVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: noninferior UDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean 3-year changes in zonal Kmax-3mm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress-strain index changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal stiffness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean rate of decline in FVC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Eating and drinking domain of ALSAQ‐40
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: VAS-score 24 hours post-procedure
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: breast drainage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volume expressed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: comfort rating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Weight stigma
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Pain-discomfort relief
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Fragility index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spherical Equivalent (SE) progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axial Length (AL) elongation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ALS algorithm knowledge posttest scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes